Substance / Medication

Duloxetine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation.
El Sharawy Amr Mostafa, Shukr Marwa Hassan, Elshafeey Ahmed Hassen · Drug Deliv · 2017
PMID: 29172829ObservationalFull text (PMC)
Determination of duloxetine hydrochloride in the presence of process and degradation impurities by a validated stability-indicating RP-LC method.
Raman N V V S S, Harikrishna K A, Prasad A V S S et al. · J Pharm Biomed Anal · 2010
PMID: 20005658Observational
Stress degradation studies on duloxetine hydrochloride and development of an RP-HPLC method for its determination in capsule formulation.
Sinha V R, [object Object], Kumria R et al. · J Chromatogr Sci · 2009
PMID: 19772733Observational
Prurigo successfully treated with duloxetine hydrochloride.
Hashimoto Takashi, Satoh Takahiro, Yokozeki Hiroo · Australas J Dermatol · 2019
PMID: 30675900Case Report
Duloxetine Hydrochloride-Induced Oral Lichenoid Reaction: A Case Report.
Kadam Nilima S, Patil Rahul A, Gurav Abhijit N et al. · Med Princ Pract · 2015
PMID: 26022117Case ReportFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Duloxetine hydrochloride (substance)
SNOMED CT
426892003
UMLS CUI
C1505020

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

3
Conditions
1
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.